Dr. Maurizio Grimaldi joined the Scientific Review Branch at NIA as a Scientific Review Officer in April 2015. Dr. Grimaldi graduated from the Medical School at the Federico II University of Napoli in Italy, with residency and board accreditation in clinical pharmacology. He has also completed a PhD in neuropharmacology and toxicology. In 1996, he moved to the US to pursue postdoctoral training at NINDS and NICHD, NIH. Dr. Grimaldi's work mostly focused on the physiology of brain cells and on drug discovery for the treatment of brain diseases. He is returning to NIA after a tenured period at the Southern Research Institute, a nonprofit research organization, where he was the leader of the Neuropharmacology Laboratory and an Adjunct Associate Professor of Neurobiology and Pharmacology at the University of Alabama at Birmingham. Having been trained in both clinical and basic sciences, he has dedicated his work to translational sciences with emphasis on possible treatments for neurologic diseases. Dr. Grimaldi was successful in securing grants from several federal and nonprofit agencies including NIA, NIMH, NIDA, Prize4Life and the Muscular Dystrophy Assocation. He holds several international patents, some of which have been acquired by drug companies and small biotech companies, resulting in medicines to treat patient ailments. He has served as an ad hoc member of several NIH, DOD, and private research foundation review panels. He is an avid cyclist and when not at work, he can be found in the Alps on his favorite bicycle.